This effect has been previously observed in other cancer entities: It was shown that EPOR signaling affected survival of EPOR expressing melanoma cells in vitro and in xenograft mice [14] and that EPO activates survival pathways in breast cancer stem-like cells and increases the resistance to chemotherapeutic agents [40]. This evidence concerns the gene EPOR and breast carcinoma.